A Clinical Study on Qilong Capsule for Apoplexy Involv ing the Meridians(Qi-Deficiency and Blood-Stasis Syndrome)
- VernacularTitle:芪龙胶囊治疗中风病中经络（气虚血瘀证）的临床研究
- Author:
Qiong ZHANG
;
Qing MIAO
;
Wei WANG
- Publication Type:Journal Article
- Keywords:
@ Qilong Capsule/therapeutic use;
stroke/TCD therapy
- From:
Traditional Chinese Drug Research & Clinical Pharmacology
2001;12(2):77-79
- CountryChina
- Language:Chinese
-
Abstract:
Objective: To assess the effect and safety of Qilong Capsule (QLC) in treating apoplexy involving the meridians (Qi-deficiency and blood-stasis syndrome ). Methods: A randomized , do uble-blinded double-dummy controlled trial was adopted. One hundred and two pati ents were treated with QLC, 101 with Xiaoshuan oral liquid (XOL ) and 200 served as the open treatment group. Results: The total effective rate in QLC group was 89.22% and symptomatic relieved rate 44.12%,showing t hat QLC was more effective than XOL（P＜0.01）.Conc lusion: QLC is effective for apoplexy involving the meridians and has no side an d toxic effects.
